Trading Signals
3 High-Potential Healthcare Stocks: Will TNXP Lead the Charge?
While in 2023, healthcare lagged despite market optimism, the industry in 2024, is poised for a resurgence. With innovative breakthroughs like GLP-1 drugs and rising US prescriptions, healthcare offers enticing prospects for investors seeking growth. Let’s explore three phenomenal healthcare stocks primed for a boom amid this broader turnaround. Tonix Pharmaceuticals Investing in healthcare? Look no further than Tonix Pharmaceuticals (NASDAQ: TNXP). As a micro-cap company, its potential is unmatched. With a vast Total Addressable Market (TAM) in CNS therapeutics—projected to reach $159.84 billion by 2030—Tonix pretty much leads the charge. Despite the complexity of CNS drug development, Tonix persists
